- Latest available (Revised)
- Point in Time (27/12/2007)
- Original (As adopted by EU)
Commission Regulation (EC) No 2073/2005 of 15 November 2005 on microbiological criteria for foodstuffs (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Version Superseded: 19/05/2010
Point in time view as at 27/12/2007.
There are currently no known outstanding effects for the Commission Regulation (EC) No 2073/2005, Chapter 1. .
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
a n = number of units comprising the sample; c = number of sample units giving values between m and M. | |||||||
b For points 1.1-1.25 m = M. | |||||||
c The most recent edition of the standard shall be used. | |||||||
d Regular testing against the criterion is not required in normal circumstances for the following ready-to-eat foods:
| |||||||
e This criterion shall apply if the manufacturer is able to demonstrate, to the satisfaction of the competent authority, that the product will not exceed the limit 100 cfu/g throughout the shelf-life. The operator may fix intermediate limits during the process that must be low enough to guarantee that the limit of 100 cfu/g is not exceeded at the end of shelf-life. | |||||||
f 1 ml of inoculum is plated on a Petri dish of 140 mm diameter or on three Petri dishes of 90 mm diameter. | |||||||
g This criterion shall apply to products before they have left the immediate control of the producing food business operator, when he is not able to demonstrate, to the satisfaction of the competent authority, that the product will not exceed the limit of 100 cfu/g throughout the shelf-life. | |||||||
h Products with pH ≤ 4,4 or a w ≤ 0,92, products with pH ≤ 5,0 and a w ≤ 0,94, products with a shelf-life of less than five days shall be automatically considered to belong to this category. Other categories of products can also belong to this category, subject to scientific justification. | |||||||
i This criterion shall apply to mechanically separated meat (MSM) produced with the techniques referred to in paragraph 3 of Chapter III of Section V of Annex III to Regulation (EC) No 853/2004 of the European Parliament and of the Council. | |||||||
j Excluding products when the manufacturer can demonstrate to the satisfaction of the competent authorities that, due to the ripening time and a w of the product where appropriate, there is no salmonella risk. | |||||||
l Only ice creams containing milk ingredients. | |||||||
k Preliminary testing of the batch of seeds before starting the sprouting process or the sampling must be carried out at the stage where the highest probability of finding Salmonella is expected. | |||||||
m Reference: Community reference laboratory for coagulase positive staphylococci. European screening method for the detection of staphylococcal enterotoxins in milk and milk products. | |||||||
n Parallel testing for Enterobacteriaceae and E. sakazakii shall be conducted, unless a correlation between these micro-organisms has been established at an individual plant level. If Enterobacteriaceae are detected in any of the product samples tested in such a plant, the batch must be tested for E. sakazakii . It shall be the responsibility of the manufacturer to demonstrate to the satisfaction of the competent authority whether such a correlation exists between Enterobacteriaceae and E. sakazakii . | |||||||
o E. coli is used here as an indicator of faecal contamination. | |||||||
p A pooled sample comprising a minimum of 10 individual animals. | |||||||
q Particularly fish species of the families: Scombridae, Clupeidae, Engraulidae, Coryfenidae, Pomatomidae, Scombresosidae . | |||||||
r Single samples may be taken at retail level. In such a case the presumption laid down in Article 14(6) of Regulation (EC) No 178/2002, according to which the whole batch is to be deemed unsafe, shall not apply. | |||||||
s References : 1. Malle P., Valle M., Bouquelet S. Assay of biogenic amines involved in fish decomposition. J. AOAC Internat. 1996, 79, 43-49. 2. Duflos G., Dervin C., Malle P., Bouquelet S. Relevance of matrix effect in determination of biogenic amines in plaice ( Pleuronectes platessa ) and whiting ( Merlangus merlangus . J. AOAC Internat. 1999, 82, 1097-1101. | |||||||
Food category | Micro-organisms/their toxins, metabolites | Sampling plan a | Limits b | Analytical reference method c | Stage where the criterion applies | ||
---|---|---|---|---|---|---|---|
n | c | m | M | ||||
1.1 Ready-to-eat foods intended for infants and ready-to-eat foods for special medical purposes d | Listeria monocytogenes | 10 | 0 | Absence in 25 g | EN/ISO 11290-1 | Products placed on the market during their shelf-life | |
1.2 Ready-to-eat foods able to support the growth of L. monocytogenes , other than those intended for infants and for special medical purposes | Listeria monocytogenes | 5 | 0 | 100 cfu/g e | EN/ISO 11290-2 f | Products placed on the market during their shelf-life | |
5 | 0 | Absence in 25 g g | EN/ISO 11290-1 | Before the food has left the immediate control of the food business operator, who has produced it | |||
1.3 Ready-to-eat foods unable to support the growth of L. monocytogenes , other than those intended for infants and for special medical purposes d h | Listeria monocytogenes | 5 | 0 | 100 cfu/g | EN/ISO 11290-2 f | Products placed on the market during their shelf-life | |
1.4 Minced meat and meat preparations intended to be eaten raw | Salmonella | 5 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.5 Minced meat and meat preparations made from poultry meat intended to be eaten cooked | Salmonella | 5 | 0 | From 1.1.2006 Absence in 10 g From 1.1.2010 Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.6 Minced meat and meat preparations made from other species than poultry intended to be eaten cooked | Salmonella | 5 | 0 | Absence in 10 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.7 Mechanically separated meat (MSM) i | Salmonella | 5 | 0 | Absence in 10 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.8 Meat products intended to be eaten raw, excluding products where the manufacturing process or the composition of the product will eliminate the salmonella risk | Salmonella | 5 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.9 Meat products made from poultrymeat intended to be eaten cooked | Salmonella | 5 | 0 | From 1.1.2006 Absence in 10 g From 1.1.2010 Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.10 Gelatine and collagen | Salmonella | 5 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.11 Cheeses, butter and cream made from raw milk or milk that has undergone a lower heat treatment than pasteurisation j | Salmonella | 5 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.12 Milk powder and whey powder | Salmonella | 5 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.13 Ice cream l , excluding products where the manufacturing process or the composition of the product will eliminate the salmonella risk | Salmonella | 5 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.14 Egg products, excluding products where the manufacturing process or the composition of the product will eliminate the salmonella risk | Salmonella | 5 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.15 Ready-to-eat foods containing raw egg, excluding products where the manufacturing process or the composition of the product will eliminate the salmonella risk | Salmonella | 5 | 0 | Absence in 25 g or ml | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.16 Cooked crustaceans and molluscan shellfish | Salmonella | 5 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.17 Live bivalve molluscs and live echinoderms, tunicates and gastropods | Salmonella | 5 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.18 Sprouted seeds (ready-to-eat) k | Salmonella | 5 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.19 Precut fruit and vegetables (ready-to-eat) | Salmonella | 5 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.20 Unpasteurised fruit and vegetable juices (ready-to-eat) | Salmonella | 5 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.21 Cheeses, milk powder and whey powder, as referred to in the coagulase-positive staphylococci criteria in Chapter 2.2 of this Annex | Staphylococcal enterotoxins | 5 | 0 | Not detected in 25 g | European screening method of the CRL for coagulase positive staphylococci m | Products placed on the market during their shelf-life | |
1.22 Dried infant formulae and dried dietary foods for special medical purposes intended for infants below six months of age | Salmonella | 30 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.23 Dried follow-on formulae | Salmonella | 30 | 0 | Absence in 25 g | EN/ISO 6579 | Products placed on the market during their shelf-life | |
1.24 Dried infant formulae and dried dietary foods for special medical purposes intended for infants below six months of age n | Enterobacter sakazakii | 30 | 0 | Absence in 10 g | ISO/TS 22964 | Products placed on the market during their shelf-life | |
1.25 Live bivalve molluscs and live echinoderms, tunicates and gastropods | E. coli o | 1 p | 0 | 230 MPN/100 g of flesh and intra-valvular liquid | ISO TS 16649-3 | Products placed on the market during their shelf-life | |
1.26 Fishery products from fish species associated with a high amount of histidine q | Histamine | 9 r | 2 | 100 mg/kg | 200 mg/kg | HPLC s | Products placed on the market during their shelf-life |
1.27 Fishery products which have undergone enzyme maturation treatment in brine, manufactured from fish species associated with a high amount of histidine q | Histamine | 9 | 2 | 200 mg/kg | 400 mg/kg | HPLC s | Products placed on the market during their shelf-life |
The limits given refer to each sample unit tested, excluding live bivalve molluscs and live echinoderms, tunicates and gastropods in relation to testing E. coli , where the limit refers to a pooled sample.
The test results demonstrate the microbiological quality of the batch tested (1) .
L. monocytogenes in ready-to-eat foods intended for infants and for special medical purposes:
satisfactory, if all the values observed indicate the absence of the bacterium,
unsatisfactory, if the presence of the bacterium is detected in any of the sample units.
L. monocytogenes in ready-to-eat foods able to support the growth of L. monocytogenes before the food has left the immediate control of the producing food business operator when he is not able to demonstrate that the product will not exceed the limit of 100 cfu/g throughout the shelf-life:
satisfactory, if all the values observed indicate the absence of the bacterium,
unsatisfactory, if the presence of the bacterium is detected in any of the sample units.
L. monocytogenes in other ready-to-eat foods and E. coli in live bivalve molluscs:
satisfactory, if all the values observed are ≤ the limit,
unsatisfactory, if any of the values are > the limit.
Salmonella in different food categories:
satisfactory, if all the values observed indicate the absence of the bacterium,
unsatisfactory, if the presence of the bacterium is detected in any of the sample units.
Staphylococcal enterotoxins in dairy products:
satisfactory, if in all the sample units the enterotoxins are not detected,
unsatisfactory, if the enterotoxins are detected in any of the sample units.
Enterobacter sakazakii in dried infant formulae and dried dietary foods for special medical purposes intended for infants below 6 months of age:
satisfactory, if all the values observed indicate the absence of the bacterium,
unsatisfactory, if the presence of the bacterium is detected in any of the sample units.
Histamine in fishery products from fish species associated with a high amount of histidine:
satisfactory, if the following requirements are fulfilled:
the mean value observed is ≤ m
a maximum of c/n values observed are between m and M
no values observed exceed the limit of M,
unsatisfactory, if the mean value observed exceeds m or more than c/n values are between m and M or one or more of the values observed are > M.]
Textual Amendments
[F1The test results may be used also for demonstrating the effectiveness of the hazard analysis and critical control point principles or good hygiene procedure of the process.]
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: